Form 8-K PACIFIC BIOSCIENCES OF For: Feb 03

Go back to Form 8-K PACIFIC BIOSCIENCES OF For: Feb 03

Pacific Bio (PACB) Reports In-Line Q4 EPS

February 3, 2016 5:08 PM EST

Pacific Bio (NASDAQ: PACB) reported Q4 EPS of ($0.02), in-line with the analyst estimate of ($0.02). Revenue for the quarter came in at $36.3 million versus the consensus estimate of $36.96 million.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.

... More